Is Minimally Invasive Glaucoma Surgery (MIGS) Right for You? A Clear, Practical Guide

Do you find yourself meticulously timing eyedrop applications, enduring the familiar sting, and wishing for a less disruptive way to manage your vision? If you’re considering minimally invasive glaucoma surgery (MIGS), you’re likely seeking a method that integrates smoothly into your daily life—allowing you more time for reading, driving, gardening, or caring for family, rather than adhering to a strict eye drop schedule. This guide summarizes current research, typical recovery, and how to prepare for your consultation, so you and your surgeon can make an informed decision together. Use this information to formulate questions and make the most of your visit to Nova Eye Institute.

A Patient Story That May Sound Familiar

Maria, in her 60s, diligently follows her morning eyedrop regimen. Despite her efforts, her eye pressure has increased, and a cataract is affecting her vision. During a clinic visit, she asks if a small, additional procedure, performed through the same tiny incision as cataract surgery, could stabilize her pressure and simplify her routine.

Her surgeon reviews her visual fields, OCT images of her optic nerve, and the angle anatomy via gonioscopy. Together, they establish realistic goals for her outcome and how progress will be measured. She leaves with a clear, personalized plan tailored to her needs.

This combination of evidence-based care, measurable goals, and consideration for daily life is the essence of MIGS: a carefully selected tool used as part of long-term glaucoma management.

What MIGS Does—In Straightforward Terms

Your eye continuously produces a clear fluid called aqueous humor. This fluid must drain through tiny channels. When outflow is restricted, pressure rises. MIGS utilizes microsurgical instruments and small implants or angle procedures, performed through tiny corneal incisions, to enhance the eye’s natural drainage pathways. These approaches can often be performed through the same small incision used for cataract surgery, potentially leading to less tissue disruption and a more comfortable early healing period for many individuals.

How MIGS Differs from Traditional Filtering Surgery

Traditional filtering procedures (e.g., trabeculectomy or tube shunts) can lower pressure more aggressively and may be necessary for advanced disease. However, they typically require closer postoperative monitoring and carry higher risks of complications. MIGS aims for a middle ground: a favorable safety profile and quicker recovery in exchange for generally more modest reductions in pressure. For many individuals with mild to moderate primary open-angle glaucoma—especially when cataract surgery is already planned—this balance is appealing.

MIGS is not a cure. It is an option within a long-term treatment plan, tailored to your pressure goals, angle anatomy, and optic nerve status.

What the Evidence Shows

Clinical studies help set expectations rather than guarantee outcomes.

Safety and Recovery: Across various MIGS techniques performed through small incisions, trials, and multicenter studies report lower rates of serious complications compared with traditional filtering surgeries. Early recovery commonly includes mild scratchiness, light sensitivity, or a foreign-body sensation, which typically improves as the eye heals. Many patients resume routine activities as directed by their surgeon.

Pressure Control: In selected patients, MIGS can lead to meaningful pressure reduction—particularly when combined with cataract surgery. Long-term randomized data indicate that adding a Schlemm’s canal microstent during cataract surgery resulted in sustained pressure lowering and a reduced need for medications over five years (Samuelson et al., “Long-Term Outcomes”).

Medication Reduction: Randomized trials of trabecular micro-bypass devices combined with cataract surgery demonstrated greater average pressure reductions and fewer glaucoma drops than cataract surgery alone at two years (Samuelson et al., “Randomized Evaluation”).

Canal-Based Approaches: Prospective multicenter data for systems that viscodilate Schlemm’s canal and address its inner wall—when performed with cataract surgery—showed significant reductions in unmedicated diurnal pressure and lower medication burden at 12 months (Gallardo et al.).

These studies collectively suggest a consistent theme: for appropriately selected patients, MIGS can lower pressure and often reduce reliance on topical medications, with a safety and recovery profile many patients consider acceptable. Your individual outcome depends on your baseline pressure, angle anatomy, optic nerve and visual field status, and your daily life requirements. Discussing these details with your ophthalmologist will translate population data into a personalized plan.

Who Is Commonly Considered a Good Candidate?

While there’s no universal answer, several patterns commonly emerge in clinical practice:

Often considered for mild to moderate primary open-angle glaucoma.
Frequently discussed when a visually significant cataract is present and a combined procedure is beneficial.
An option for individuals who experience side effects or practical difficulties with long-term topical medications.

MIGS may be less appropriate when:

Very low target pressures are required for advanced disease.
The angle anatomy is significantly altered or scarred, limiting surgical access.
The glaucoma subtype involves angle-closure mechanisms (these situations require careful assessment with gonioscopy and imaging).

Your surgeon will consider your baseline and target pressures, OCT and visual field findings, gonioscopy, corneal thickness, ocular surface health, and your daily activities and priorities when recommending a path forward. Your life experience is as important as your test results.

How Main MIGS Approaches Work (Plain Language)

MIGS is best understood as a toolbox of approaches designed to reduce resistance along the eye’s drainage pathway. Common categories include:

Trabecular bypass or stenting: Tiny implants or bypasses that help fluid flow through the trabecular meshwork into Schlemm’s canal.
Goniotomy and trabecular excision: Microscopic incisions or tissue removal in the trabecular meshwork to create a clearer pathway into Schlemm’s canal.
Canal-based procedures: Techniques that viscodilate Schlemm’s canal and distal collector channels and, when appropriate, open the canal’s inner wall to re-establish broader outflow.
Subconjunctival micro-stents: Small devices that create an alternate drainage pathway beneath the conjunctiva; these can offer larger pressure reductions in some eyes but typically require closer postoperative management.

The specific device or approach that is right for you depends on your anatomy, pressure goals, surgeon experience, and preferences.

Preparing for a Consultation—What to Bring and Expect

Thorough preparation enhances the consultation. Please bring:

Your current eyedrop list and any eye-related records or devices you have.
Prior visual field tests, OCT images, operative reports, or clinic notes if you’ve seen another eye doctor.
A concise list of your priorities (e.g., reduce drops, improve night driving, return to hobbies).

Expect a comprehensive workup: repeated pressure checks to confirm baseline and variability, gonioscopy to view the angle, OCT imaging of the optic nerve and retinal nerve fiber layer, and visual field testing. You will also discuss whether combining cataract surgery with MIGS is appropriate, what follow-up will entail, and which symptoms should prompt an urgent call.

For practical logistics, plan transportation home on the day of surgery, allow time for preoperative testing, and confirm insurance coverage. Nova Eye Institute accepts Medicare, Medi-Cal, and many private plans; our team can help verify your benefits and address potential coverage questions. Same-day evaluation appointments may be available.

What Surgery Day Is Usually Like

Many patients describe a calm environment: numbing drops, a gentle drape, and quiet, focused care. When MIGS is combined with cataract surgery, these steps are often performed through a single small incision and can take only minutes within the overall procedure. Most individuals do not experience sharp pain during the operation, though sensations such as pressure or brief movement are common. Before you leave, our team provides personalized aftercare instructions, a protective shield if needed, and clear contact information for questions between visits.

Typical Recovery Timeline (Realistic Expectations)

Healing varies by individual, but many people experience similar milestones:

First 24–48 hours: Mild scratchiness, tearing, glare, and blurring are common. Rest, protective eyewear, and sunglasses can enhance comfort.
First week: Vision often stabilizes, and redness decreases; light activities—such as reading, walking, and gentle computer work—are usually permitted as directed by your surgeon.
Weeks 1–4: Ongoing healing with pressure checks to monitor your eye’s response; your medication plan may be adjusted.
Three months and beyond: A longer-term pressure pattern emerges. Some individuals continue certain drops, while others reduce medications. Lifelong monitoring remains essential.

Your follow-up schedule will be individualized based on your procedure and eye.

Risks and Realistic Trade-Offs

All surgical procedures carry risks. Common postoperative issues reported with MIGS include transient pressure spikes, mild intraocular bleeding that resolves over time, inflammation that responds to standard care, device-specific issues such as blockage or malposition, and the possibility of additional procedures if pressure goals are not met. The durability of results varies by technique and individual: some procedures provide lasting benefit for years, while others may diminish over time and require future interventions. These possibilities are part of a staged, long-term approach to protecting your vision.

Questions to Bring to Your Appointment

Keeping a concise list helps ensure you leave with useful answers. Consider asking:

Which MIGS approach best suits my anatomy and target pressure, and why?
Will we combine MIGS with cataract surgery, and how would that affect recovery?
How will we define success, and within what timeframe?
What are realistic expectations for my pressure and medication use?
If my pressure remains above target, what are the next options?
What follow-up schedule and tests should I expect?

How Nova Eye Institute Supports You

At Nova Eye Institute, our goal is to combine evidence-based care with personalized attention. You will meet experienced glaucoma and cataract surgeons who use advanced diagnostic tests—gonioscopy, OCT, and visual field testing—to assess candidacy and monitor progress. We offer access to a broad range of MIGS options and modern surgical care, tailoring recommendations to your clinical needs and daily life. Our locations in Glendale and, soon, Porter Ranch, serve patients throughout Santa Clarita, Valencia, Glendale, Glendora, Pasadena, Lancaster, Palmdale, and neighboring communities. We accept Medicare, Medi-Cal, and many private plans; our team can help verify your benefits and arrange appointments, including same-day evaluations when appropriate.

We also offer a Concierge IOL experience for cataract patients and an eShop with doctor-recommended eye care products. Above all, we aim to keep you informed and comfortable so you can make decisions that align with your priorities.

A Thoughtful Next Step

If Maria’s story resonates with you, you are not alone—and you don’t have to make an immediate decision. With clear expectations, consistent follow-up, and a plan aligned with your lifestyle, MIGS can be a practical, evidence-based option within a long-term glaucoma strategy. Bring your questions, eye records, and a concise list of what matters most to you—whether it’s nighttime reading, confident driving, or spending time with family—and we will help you weigh your options.

To explore whether MIGS is appropriate for you, schedule a glaucoma consultation at Nova Eye Institute. Our team will review your history, answer your questions, and help you understand the next steps.

This information is for educational purposes only and does not constitute medical advice. Always speak with your ophthalmologist about diagnosis, treatment choices, medications, and recovery instructions.

Works Cited

Gallardo MJ, Supnet RA, Ahmed I. “Canaloplasty and Trabeculotomy with the OMNI Surgical System in Combination with Cataract Surgery for Primary Open-Angle Glaucoma: Prospective, Multicenter 12-Month Results (GEMINI).” Journal of Cataract & Refractive Surgery. 2021;47(10):1282–1293.

Samuelson TW, Chang DF, Marquis R, et al. “Long-Term Outcomes of a Schlemm’s Canal Microstent Combined with Cataract Surgery: Five-Year Results of a Randomized Controlled Trial.” Ophthalmology. 2022;129(7):979–991.

Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE, for the iStent inject Study Group. “Randomized Evaluation of the iStent inject Trabecular Micro-Bypass in Primary Open-Angle Glaucoma Combined with Cataract Surgery.” Ophthalmology. 2019;126(6):811–821.